Jazz Pharmaceuticals Announces Webcast Discussion of Data to be Presented at APSS

DUBLIN, May 24, 2018 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will host a webcast to discuss data to be presented on solriamfetol (JZP-110) and Xyrem® (sodium oxybate) oral solution at the Annual Meeting of the Associated Professional Sleep...

from PR Newswire: //https://ift.tt/2IMJpLp